SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-088825
Filing Date
2023-11-20
Accepted
2023-11-20 17:11:39
Documents
3
Period of Report
2023-12-15

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a1123_jaspertherap.htm DEF 14A 457517
2 GRAPHIC tproxy_001.jpg GRAPHIC 1388488
3 GRAPHIC tproxy_002.jpg GRAPHIC 1032599
  Complete submission text file 0001213900-23-088825.txt   3793920
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39138 | Film No.: 231423578
SIC: 2836 Biological Products, (No Diagnostic Substances)